Rap1Gap promoter was found to be hypermethylated in RCC cell lines—SN12C and Caki-1—and treatment with decitabine (5-aza-2′-deoxycytidine) of SN12C cells significantly increased the relative expression of Rap1Gap. The gene discussed is RAP1GAP; the disease is renal cell carcinoma.